Grace Therapeutics (GRCE) Earnings Date, Estimates & Call Transcripts $2.97 0.00 (0.00%) As of 05/23/2025 03:48 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Grace Therapeutics Earnings Summary Grace Therapeutics posted Q3 2025 earnings on February 13, 2025, reporting an EPS of -$0.26, which topped the consensus estimate of -$0.27 by $0.01. With a trailing EPS of -$1.16, Grace Therapeutics' earnings are expected to grow next year, from ($1.06) to ($0.75) per share. Upcoming Q4 Earnings DateJun. 20Before Market OpensEstimatedConsensus EPS (Feb. 13) -$0.27 Actual EPS (Feb. 13) -$0.26 Beat By $0.01 Q3 2025 Earnings ResourcesQ3 2025 Earnings Report Press Release (8-K)GRCE Upcoming EarningsGrace Therapeutics' Q4 2025 earnings is scheduled for Friday, June 20, 2025, with a conference call scheduled on Monday, June 23, 2025 at 9:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Grace Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Grace Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Grace Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ2 20251-$0.31-$0.31-$0.31Q3 20251-$0.24-$0.24-$0.24Q4 20252-$0.25-$0.20-$0.23 Grace Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 6/20/2025(Estimated)--------2/13/2025Q3 2025-$0.27-$0.26+$0.01-$0.36-- Grace Therapeutics Earnings - Frequently Asked Questions When is Grace Therapeutics's earnings date? Grace Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, June 20th, 2025 based off last year's report dates. Learn more on GRCE's earnings history. Did Grace Therapeutics beat their earnings estimates last quarter? In the previous quarter, Grace Therapeutics (NASDAQ:GRCE) reported ($0.26) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.27) by $0.01. Learn more on analysts' earnings estimate vs. GRCE's actual earnings. How much profit does Grace Therapeutics generate each year? Grace Therapeutics (NASDAQ:GRCE) has a recorded net income of -$12.85 million. GRCE has generated -$1.16 earnings per share over the last four quarters. What is Grace Therapeutics's EPS forecast for next year? Grace Therapeutics's earnings are expected to grow from ($1.06) per share to ($0.75) per share in the next year. More Earnings Resources from MarketBeat Related Companies Black Diamond Therapeutics Earnings Date Alpha Cognition Earnings Date Vigil Neuroscience Earnings Date Neumora Therapeutics Earnings Date RAPT Therapeutics Earnings Date BioHarvest Sciences Earnings Date Contineum Therapeutics Earnings Date Sagimet Biosciences Earnings Date Cassava Sciences Earnings Date HilleVax Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH StockAdvance Auto Parts Jumps on Surprise Earnings BeatAlibaba's Earnings Just Changed Everything for the StockCisco Stock Eyes New Highs in 2025 on AI, Earnings, UpgradesSymbotic Gets Big Earnings Lift: Is the Stock Investable Again?D-Wave Pushes Back on Short Seller Case With Strong EarningsAppLovin Surges on Earnings: What's Next for This Tech Standout? This page (NASDAQ:GRCE) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Grace Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Grace Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
